| Last Price | Today's Change | 52-Week Range | Trading Volume |
|---|---|---|---|
| 16.53 | -0.34 (-2.02%) | 9.85 - 17.05 | 12.0 thousand (Below Avg) |
Market data as of 2:12PM 06/19/13. Quotes are delayed by at least 15 min.
| Open | 16.83 |
|---|---|
| Previous Close | 16.87 |
| Day's Range | 16.50 - 16.90 |
| Market Cap | 343.3M |
| Avg Volume (10 Day) | 79.1K |
| Price/Earnings (Trailing 12 Mo.) | 14.5x |
| Earnings Per Share (Trailing 12 Mo.) | 1.16 |
| Dividend Yield | No Dividend |


These seven metrics are a snap to calculate, thanks to Quicken.com's One-Click Scorecard. Our goal with this tool is to help you evaluate potential investment candidates and eliminate those equities that aren't up to snuff. One-Click Scorecard won't do all the homework necessary for you to reach a decision, but it will help you develop a list of quality stocks to watch and study further.
| Performed well consistently? | Fail |
|---|---|
| Avoids excess debt? | Fail |
| Converting sales to profits? | Fail |
| Shareholder's money handled rationally? | Fail |
| Increased shareholder value? | Fail |
| Consistently increased owner earnings? | Fail |
| Sells at 25% discount to intrinsic value? | Pass |


These eight metrics are a snap to calculate, thanks to Quicken.com's One-Click Scorecard. Our goal with this tool is to help you evaluate potential investment candidates and eliminate those equities that aren't up to snuff. One-Click Scorecard won't do all the homework necessary for you to reach a decision, but it will help you develop a list of quality stocks to watch and study further.
| Pays a cash dividend? | Fail |
|---|---|
| Room to increase dividends? | Fail |
| Increased earnings over time? | Pass |
| Borrows within reasonable limits? | Pass |
| Stock is undervalued? | Pass |
| Have investors caught on? | Fail |
| Has support of institutional investors? | Fail |
| Has sufficient liquidity? | Pass |
no!no!™ Hair Launches The "Design It Yourself" Contest
PR Newswire - Thursday 05/30/2013 7:00 AM ET
| PHMD | Industry Range | |
|---|---|---|
| Revenue Growth (1yr) | 30.70% | |
| Net Income Growth (1yr) | 251.33% | |
| Total Debt/Equity | 0.00 | |
| LT Debt/Equity | 0.00 | |
| Earnings Yield | 6.90% | |
| Price/Sales | 1.54 |
| Company | Last | Change |
|---|---|---|
| Navidea Biopharmaceuticals Inc | 2.65 | -0.38% |
| Genmark Diagnostics Inc | 9.88 | +3.24% |
| Syneron Medical Ltd | 8.48 | -1.40% |
| Cynosure Inc | 24.30 | +0.04% |
| Symmetry Medical Inc | 7.76 | -2.63% |
Data is delayed by at least 15 min.